People

Search Language

中文(台灣) / Traditional Chinese | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(Technology & Innovation)
  • x(Technology Companies Group)
  • clear all

152 items matching filters

Search Results

Practice:

  • Technology & Innovation Sector
  • Technology Transactions
  • Intellectual Property
  • Patents
  • Trade Secrets Litigation
  • Strategic Advisory & Government Enforcement (SAGE)

Benedikt Migdal Partner

Düsseldorf

Benedikt advises on structuring and negotiating the IP aspects of corporate transactions, including M&A, divestments and venture investments as well as of commercial transactions where intellectual property rights and know-how are key assets. His work encompasses, for example, IP licensing and technology transfer agreements, engineering services agreements, transition services agreements, R&D collaborations, and IP aspects of contracts throughout the life sciences sector.

Benedikt is also an experienced patent and trade secret litigator and has represented German and international clients from a range of industries in complex disputes, especially concerning patents and know-how in the fields of mobile telecommunication/connectivity and the life sciences.

Based on his extensive experience in both IP transactions and litigation, he deeply understands the full range of legal and economical issues that technology-driven companies are challenged with in context with IP. This also includes IP-related competition law issues, such as FRAND-requirements for licensing and enforcing standard essential patents as well as issues arising in connection with EU regulations concerning technology transfers.

322586

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Andrew W. Miller Senior Associate

San Francisco

As a Senior Associate in Orrick’s Technology Companies Group, Andrew leverages his experience as a general counsel, operator and investor to guide clients through all stages from startup to exit. He is a trusted advisor on board governance, venture capital transactions, general employment and commercial matters, conflict resolution, mergers & acquisitions and public offerings. Andrew also counsels venture funds in structuring deals and assists them in identifying and managing the various risks associated with their investments.

 
Prior to re-joining Orrick in 2022, Andrew was employee number 2 at a venture-backed food technology/CPG startup where, in addition to acting as General Counsel, he established the finance, accounting, HR and operations management functions of the company and served on the executive management team responsible for defining and executing the company’s strategic initiatives.


Andrew began his legal career as an associate with Orrick’s Technology Companies Group in 2016 and is the recipient of the Firm’s 2019 Alan Talkington Mentorship Award. He also has experience working for venture funds and technology startups and is an active angel investor.

 
Andrew lives in Colorado with his wife, daughter and labradoodle. In his spare time, you can often find him hiking, fly fishing and skiing.

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Fintech

Jamie Moore Partner

London

Jamie acts for both early and late stage companies in intellectual property rich sectors and those who invest in them, including some of the most active venture capital funds, corporate or individual investors.

Jamie has a passion for disruptive technologies, innovation and entrepreneurial business. He has acted on countless transactions across a broad range of sectors both in the UK and internationally, but is most known for his experience in acting on investments into fintech and Artificial Intelligence companies.

Jamie has deep knowledge of the practice area in which he operates and market trends, which he leverages to provide clear and concise advice on a range of corporate issues taking high growth technology companies from start-up through to exit.

He presents on corporate law and venture capital to clients and at seminars in the City, including practitioners’ conferences on practical legal issues in venture capital transactions and SEIS/EIS investments.

An active participant in the venture capital community, Jamie Moore has contributed to industry standard form documentation, acted as a mentor for various Seedcamp portfolio companies and hosted office-hours for the Barclays' TechStars cohort.

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Mergers & Acquisitions
  • Life Sciences & HealthTech

Mike O'Donnell Partner

Silicon Valley

Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.

He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.

Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.

Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.

 

436263

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Jake Ornstein Partner

New York

Jake provides strategic advice and counsel to startup founders and high-growth technology companies, as well as venture capital and other private equity funds.

He has broad experience in corporate and transactional matters, including venture capital financings, mergers and acquisitions and corporate formation and governance matters. He works closely with founders and technology company clients from a wide variety of industries to provide outside general counsel services and strategic business insights.

Jake also works extensively with venture capital and other private equity funds in their investment activities in the US and internationally, including early-stage to growth equity financings, mergers and acquisitions and secondary liquidity transactions.

182632

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Blockchain & Digital Assets
  • Japan
  • Mergers & Acquisitions

Joseph Perkins Partner

Silicon Valley

In the fast-paced and unprecedented blockchain and cryptocurrency markets, Joseph helps companies develop innovative and comprehensive legal strategies to achieve their goals of bringing to market disruptive and transformative technologies. From DAO and NFT creation, general corporate and fundraising strategies, to navigating complex and changing regulatory regimes, Joseph has become a go-to advisor for companies in the blockchain and virtual currency ecosystem.

As a member of Orrick’s Technology Companies Group, Joseph assists cutting-edge technology companies and investors with general corporate counseling, private venture capital financing, and M&A services. Joseph has had the opportunity to work with some of the most iconic companies in Silicon Valley, advising on corporate strategy and fundraising matters.

Joseph plays a key role in connecting the Silicon Valley and Japan tech and venture ecosystems. He advises Japanese technology companies and corporate venture capital funds, leveraging his Silicon Valley background to support their growth. Fluent in Japanese, Joseph maintains strong ties to Japanese businesses and collaborates closely with Orrick’s Tokyo practice.